FingerprintDive into the research topics of 'Phase I/II trial of gemcitabine plus cyclophosphamide in patients with metastatic breast carcinoma previously treated with taxanes'. Together they form a unique fingerprint.
- Sort by
Huda S. Salman, Katie Tanaka, Joseph A. Sparano
Research output: Contribution to journal › Article › peer-review